Trademarkia Logo

Canada

C$
Trademark Search in Canada
BIODEXA

View On IC.GC.CA

BIODEXA
SEARCHED

on 6 Jan 2025

Last Applicant/ Owned by

BIODEXA PHARMACEUTICALS LIMITED

1 Caspian Point,Caspian WayCardiff CF10 4DQ

GB

Serial Number

2285397 filed on 4th Sept 2023

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

BIODEXA

Trademark usage description

custom manufacture of pharmaceuticals; 3d printing; custom 3d printing for others; 3d printing and custom 3d printing in the fields of pharmaceuticals Read More

Classification Information

Class [040]
Custom manufacture of pharmaceuticals; 3D printing; custom 3D printing for others; 3D printing and custom 3D printing in the fields of pharmaceuticals and medicines; 3D printing and custom 3D printing in the field of drug delivery; information, advisory and consultancy services relating to the aforesaid.

Classification kind code

12

Class [042]
Pharmaceutical and drug development services; providing medical and scientific research information in the field of pharmaceuticals; scientific research, design and analysis in the field of drug delivery; technological services in the field of drug delivery; information, advisory and consultancy services relating to the aforesaid.

Classification kind code

12

Mark Details

Serial Number

2285397

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 6th Jan 2025		Search Recorded
Submitted for opposition 20
on 6th Jan 2025		Examiner's First Report
Submitted for opposition 223
on 6th Jan 2025		Total Provisional Refusal
Submitted for opposition 256
on 5th Aug 2024		Notification of Possible Opposition Sent
Submitted for opposition 48
on 9th Jan 2024		Agent Changed
Submitted for opposition 257
on 5th Oct 2023		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 5th Oct 2023		Formalized
Submitted for opposition 1
on 5th Oct 2023		Created
Submitted for opposition 228
on 4th Sept 2023		International Registration
Submitted for opposition 30
on 4th Sept 2023		Filed